KALLI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 3.985
AS - Asia 58
SA - Sud America 10
AF - Africa 3
NA - Nord America 2
Totale 4.058
Nazione #
IT - Italia 3.984
CN - Cina 41
VN - Vietnam 11
BR - Brasile 8
SG - Singapore 4
US - Stati Uniti d'America 2
ZA - Sudafrica 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
EC - Ecuador 1
ID - Indonesia 1
Totale 4.058
Città #
Genova 2.222
Genoa 1.177
Rapallo 317
Vado Ligure 257
Beijing 19
Bordighera 11
Ashburn 2
Hanoi 2
Singapore 2
Abidjan 1
Barra Bonita 1
Biên Hòa 1
Bogra 1
Bình Dương 1
Bắc Ninh 1
Caxias do Sul 1
Hacienda Ibarra 1
Ho Chi Minh City 1
Hải Dương 1
Iguaí 1
Itabaiana 1
Johannesburg 1
José C. Paz 1
Maceió 1
Nhandeara 1
Phú Thọ 1
Rio de Janeiro 1
Robertson 1
São Bernardo do Campo 1
Vienna 1
Vinh 1
Totale 4.031
Nome #
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system 199
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer 198
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one 192
White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorder 189
Abscisic acid ameliorates the systemic sclerosis fibroblast phenotype in vitro. 187
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice 187
Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. 184
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence 170
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma 167
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice 166
Generation of more effective cancer vaccines. 165
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes 162
Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. 155
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 152
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. 151
Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells. 148
Impaired immune response to Candida albicans in cells from Fanconi anemia patients 142
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients. 141
CD8+CD28-CD127loCD39+ T reg: a new biomarker for HIV infection 121
Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia Areata. 119
AIRE POLYMORPHISMS INDUCE VARIABLE EXTENT OF APOPTOSIS ON MELANOMA SPECIFIC CD8+T LYMPHOCYTES 118
Immunoregulatory T circuits, not only CD4+Treg lymphocytes 116
Phenotypic alterations involved in CD8+ treg impairment in systemic sclerosis 116
null 111
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 107
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 105
Phenotypic alterations of treg populations in systemic sclerosis 105
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients 46
Totale 4.119
Categoria #
all - tutte 13.484
article - articoli 12.239
book - libri 0
conference - conferenze 1.245
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.968


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021216 0 0 0 0 8 29 33 33 23 40 27 23
2021/2022383 7 15 39 30 33 15 17 82 20 45 20 60
2022/2023381 33 51 1 45 58 62 2 20 49 5 51 4
2023/2024262 9 22 5 33 21 55 22 12 12 14 17 40
2024/2025748 34 48 23 57 70 58 106 176 5 33 77 61
2025/2026448 174 18 120 122 14 0 0 0 0 0 0 0
Totale 4.119